This entry is part 2 of 2 in the series HIV Co-Production
On Wednesday 6 July 2022, 25 stakeholders met at Lift, Islington (a community venue) to reflect, create and share ideas together as a group about co-producing HIV research using the example of a recent participatory project exploring the impact of COVID-19 on people living with HIV in the UK
The showcase event was co-designed to be interactive and participatory in nature (after all, we wanted to showcase how valuable these approaches can be to research!). You can find out more about how we co-designed the day in our previous blog.
This entry is part 1 of 2 in the series HIV Co-Production
Over the last 18 months we have been working in partnership as a group of researchers and people living with HIV (two peer researchers and three advisory group members to undertake a co-produced peer research qualitative study exploring the experiences of COVID-19 among people living with HIV. This work is a collaboration between the Patient Experience Research Centre at Imperial College London and Positively UK.
As part of this participatory study, co-researchers undertook training on research ethics, the fundamental aspects of qualitative research, how to conduct and analyse interviews online and emotional wellbeing/safeguarding while undertaking research.
This week has marked National HIV Testing Week. This year’s campaign focusses on promoting regular testing among the most affected population groups, to reduce the number of people diagnosed late and living with undiagnosed HIV.
Why test for HIV?
People can live with HIV and display no symptoms for several years so testing is essential to know your HIV status. Being diagnosed as early as possible helps reduce transmission, allows you to start treatment early and ultimately improves health outcomes. With effective treatment, there is no risk of passing the virus on to sexual partners (Undetectable = Untransmittable).